Suppr超能文献

垂体肿瘤患者的基础催乳素水平及促甲状腺激素释放激素刺激后的催乳素水平

Basal and TRH-stimulated prolactin in patients with pituitary tumours.

作者信息

Lamberts S W, Birkenhäger J C, Kwa H G

出版信息

Clin Endocrinol (Oxf). 1976 Nov;5(6):709-11. doi: 10.1111/j.1365-2265.1976.tb03873.x.

Abstract

The diagnostic value of the assessment of prolactin (PRL) secretion in reaction to thyrotrophin releasing hormone (TRH) was investigated in twenty-four patients who had all radiological signs of a pituitary tumour and symptoms of hypogonadism and/or galactorrhoes. It was found that in these patients a PRL response to TRH can be present or absent, independent of the size of the tumour and/or the presence of suprasellar extension of the tumour. The measurement of several basal plasma PRL concentrations in combination with lateral tomography of the sella turcica seem to be a good screening for the existence of a prolactin producing pituitary adenoma and no important additional information is obtained by a TRH-test.

摘要

对24例具有垂体瘤所有放射学征象以及性腺功能减退和/或溢乳症状的患者,研究了促甲状腺激素释放激素(TRH)刺激下催乳素(PRL)分泌评估的诊断价值。结果发现,在这些患者中,PRL对TRH的反应可能存在或不存在,与肿瘤大小和/或肿瘤鞍上扩展的存在无关。测定多个基础血浆PRL浓度并结合蝶鞍侧位断层扫描似乎是筛查催乳素分泌型垂体腺瘤存在与否的良好方法,TRH试验并未提供重要的额外信息。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验